The Central Nervous System (CNS) was long thought to be an "immune-privileged" organ, highly protected from peripheral immune monitoring because of the lack of "classical" lymphatic drainage. However, this long-held theoretical dogma was radically altered by the identification of a functionally active lymphatic system lying in wait in the meningeal layers beneath the dura mater. This "hidden" lymphatic system possesses a highly organized architecture to support the selective transfer of immunocytes, antigens, and cerebrospinal fluid constituents from the brain to lymph nodes in the peripheral torso. New findings suggest an essential role for the "hidden" lymphatic system in brain health to selectively modulate immune tolerance responses, prevent pathological neuroinflammatory injury, and provide efficient clearance of toxic metabolic by-products of neural function. By selectively transporting T lymphocytes, antigen-presenting cells, as well as soluble mediators from the brain to peripheral lymph nodes, meningeal lymphatic aggregations create an essential regulatory link providing cross-talk between the CNS immunological system and peripheral immunity. However, experimental manipulation of these lymphatic aggregations in the brain indicates disturbed immunological regulation, retention of pathological "toxic" proteins in the brain, such as amyloid-β, as well as tauopathy abnormal aggregations leading to accelerated impairment in brain function. On the contrary, increased lymphatic function was able to improve these pathological impairments in preclinical studies.

The concept of brain lymphatic aggregations not only illuminates a new paradigm in immunological understanding of the brain but also offers new promise for therapy in the varying neuro-pathologies associated with dementia caused by either inflammation or cerebrovascular injuries.

The delicate equilibrium for maintaining the health of the nervous system is intricately linked with the correct balancing act between immune protection and immune privilege. Historically understood to be immunologically separated from the rest of the immune systems in the body, the central nervous system (CNS) was presumed to lack the normal lymphatic system and be protected by the blood–brain barrier [1,2]. This understanding of immune privilege has long influenced the progress of research and understanding in the field of neuroscience. But there has been growing recognition that the immune surveillance in the CNS is not a passive process but rather an active event involving specific pathways [3-5].

The identification of functioning lymphatic vessels within the meninges represents a paradigm shift within neuroimmunology [6,7]. These invisible vessels are shown to express traditional lymphatic vessel endothelial markers and offer a direct pathway between cerebrospinal fluid and interstitial tissue to the deep cervical lymph nodes [1,2,6–9]. This represents a mechanism through which immune cells and antigens produced by the central nervous system are constantly accessed by the peripheral immune system, ensuring that immune tolerance is still maintained while preventing unchecked inflammation [10–12].

In addition to the immune surveillance role, the presence of meningeal lymphatic vessels is also important in the clearance of metabolic waste products as well as fluid constituents. This is crucial within the CNS for the survival of the neuron. However, the loss or pathological impairment associated with aging within the brain has been shown to increase the level of neuroinflammatory factors, reduce the clearance of proteins, and increase susceptibility to various neuroinflammatory diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis [8,9,14-18]. Additionally, recent literature suggests the significance of the meningeal lymphatic system within the CNS in the regulation of the microglial cell function, the function of the white blood cells, as well as the cytokine level.

Experimental models reveal that it is possible to increase lymphatic ability to remove amyloid-β, tau, or α-synuclein, thus delaying cognitive dysfunction and diminishing neuroinflammation [9,12,14,22-24]. The above findings point to a unifying pathological mechanism, potentially attributed to lymphatic dysfunction, that might be common among different neurological disorders. The knowledge gained on these vessels is fundamental not only to basic neuroscience research, as mentioned above, but also to establishing a therapeutic approach targeting the immunological removal pathway in those conditions [25].

Discovery of Brain Lymphatic Vessels

The absence of lymphatic endothelial vessel-specific antigens in these areas had long been thought indicative of a lymphatic nature, although advanced imaging and molecular studies proved these to express lymphatic markers such as LYVE-1, PROX-1, and PDPN, at least in some dural vessels, thereby proving their true lymphatic nature [1].

Lymphatic Vasculature and the Trafficking

Immunologically driven T cell and antigen-presenting cell physiological trafficking along the lymphatics of the meninges allows the brain to achieve immune tolerance and regulate immunoresponses [6,7,10]. This eliminates excessive inflammatory reactions, and the brain undergoes immunosurveillance to achieve protection from infections and malignancies [11].

Role in Neurodegenerative and Inflammatory Diseases

Impaired lymphatic transport contributes to the accumulation of amyloid-β, the progression of cognitive dysfunction, and the enhancement of neuroinflammation in models of Alzheimer’s disease [8,9,14,22]. The same mechanisms have been suggested in multiple sclerosis, stroke, and brain trauma [10-12,15-18,23]. Promoting lymphatic function has been shown to increase the clearance of waste and improve.

Research Methodology

A systematic review approach was used. A search of online databases (PubMed and Scopus) for English-language studies published between 2015 and 2025 with the key terms “meningeal lymphatics,” “brain immune drainage,” and “neuroimmune interaction” was conducted. Experimental studies, observations, and intervention studies were sought. Information regarding the type of immune cell, mechanism of transport, and neurological outcome was gathered between studies 1 and 25.

Given the heterogeneity of study design, a qualitative analysis was mainly conducted. Whenever possible, a summary of effect sizes and confidence intervals from animal and human studies was performed. Trends of lymphatic dysfunction to neurological outcomes were described comparatively for different models of disease [1-25]. Results. In all the studies reviewed, functional lymphatics in the meningeal space were shown to be correlated with effective trafficking of immune cells and lowered neuroinflammation.

In general, working lymphatics in the meningeal room responded well to a well-functioning immune cell shift and a lack of neuroinflammatory signs between the inspected studies [6,7,10-12,19]. Ablation or injured languid vessel function accompanying growing age was visualized to cause a profound state of vulnerable order dysfunction, proteinopathy, and neuronal pathologies among the inspected studies [8,9,14-18,23]. Conversely, stimulation of lymphangiogenesis improved waste clearance and behavioral outcomes in preclinical models [9,12,24,25].

A big suggestion of the study is the distinguishing duty of the meningeal lymphatic vessels within the CNS as a key modulator of the immune equilibrium within the CNS. It is through these containers that the departure of the invulnerable cells and the presentation of antigens is likely. Their breakdown is the coarse road of many CNS afflictions because of languid timbre analysis [1-25].

                                                                                     Table 1: Functional Role of Meningeal Lymphatic Vessels in Neural Health.

                                                                                Figure 1: Mechanistic Pathway of Immune Cell Transport via Hidden Brain Lymphatic Vessels.

The secret languid ships of the brain are very important for the transport of vulnerable containers and the healthy support of the central nervous system. The protection and rehabilitation of the languid plan have been projected to have the potential to treat neuro-inflammatory and neurodegenerative disease [1-25].

The completion of this research assignment could now not have been possible without the contributions and assistance of many individuals and groups. We’re. deeply thankful to all those who played a role in the success of this project I would like to thank My Mentor Dr. Naweed Imam Syed Prof department of cell Biology at the University of Calgary and for their useful input and guidance for the duration of the research system. Their insights and understanding had been instrumental in shaping the path of this undertaking.

Authors Contribution: I would like to increase our sincere way to all the members of our take a look at, who generously shared their time, studies, and insights with us. Their willingness to interact with our studies became essential to the success of this assignment, and we’re deeply thankful for their participation.

Conflict of Interest: The authors declare no conflict of interest.

Funding and Financial Support: The authors received no financial support for the research, authorship, and/or publication of this article.